| Name | Title | Contact Details |
|---|---|---|
Mark Buttkus |
Chief Technology Officer | Profile |
Hemispherx Biopharma, Inc., a specialty pharmaceutical company, engages in the clinical development of new drug therapies based on natural immune system enhancing technologies for the treatment of viral and immune based chronic disorders. Its products include Ampligen, which is under clinical development for the treatment of Chronic Fatigue Syndrome, Hepatitis B, human immunodeficiency virus (HIV), renal cell carcinoma, and malignant melanoma; Alferon N Injection, an injectable formulation of natural alpha interferon for the treatment of certain categories of genital warts; and Alferon LDO, a low-dose oral liquid formulation of natural alpha interferon for the treatment of influenza and other emerging viral diseases. Hemispherx Biopharma, Inc. was founded in 1990 and is headquartered in Philadelphia, Pennsylvania.
The Kentucky Association of Health Care Facilities/Kentucky Center for Assisted Living (KAHCF/KCAL) is the trade association that represents propriety and non-proprietary nursing facilities, personal care homes, and assisted living communities across the Commonwealth. One of the state affiliates of the American Health Care Association/National Center for Assisted Living (AHCA/NCAL), KAHCF/KCAL provides a wide variety of services to member facilities including legislative and regulatory activities, professional development, statewide recognition programs, publications, media relations, research and advocacy relations.
Sirona Dental Systems, Inc. (Sirona) is a manufacturer of dental equipment. Sirona focuses on developing innovative systems and solutions for dentists globally.
Westview Acres Care Ctr is a Leon, IA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
HealthReveal is a clinical AI company dedicated to improving outcomes and quality of life for patients with chronic disease by enabling clinicians to deliver the most effective evidence-based treatments tailored to each patient’s unique circumstances, every time. By using machine learning and bridging each patient’s information with the latest medical guidelines, we predict individual patient health risks and disease progression and prescribe individual treatment interventions to mitigate risks, improve quality and reduce costs.